San Diego, CA, United States of America

Michael E Morgan

USPTO Granted Patents = 3 

Average Co-Inventor Count = 8.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
3 patents (USPTO):

Title: Michael E. Morgan: Innovator in Pharmaceutical Science

Introduction

Michael E. Morgan is a prominent inventor based in San Diego, California. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative treatments for various disorders. With a total of 3 patents to his name, Morgan's work has the potential to impact the lives of many individuals suffering from metabolic and neurological conditions.

Latest Patents

Morgan's latest patents include groundbreaking inventions related to the GPR119 receptor and modified-release dosage forms for weight management. His first patent focuses on GPR119 receptor agonists, which are useful in treating disorders such as type 2 diabetes, obesity, and other metabolic-related conditions. The specific compounds he has developed include various forms of 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)benzamide and their pharmaceutically acceptable salts.

The second patent addresses methods for weight management utilizing modified-release dosage forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts. This invention aims to provide effective solutions for individuals seeking to manage their weight through innovative pharmaceutical approaches.

Career Highlights

Michael E. Morgan is currently associated with Arena Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Arena Pharmaceuticals has positioned him as a key player in the pharmaceutical industry, contributing to the development of novel therapeutic agents.

Collaborations

Morgan has collaborated with notable colleagues, including Zezhi Jesse Shao and Anthony C. Blackburn. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective pharmaceutical solutions.

Conclusion

Michael E. Morgan's contributions to pharmaceutical science through his patents and collaborations highlight his commitment to improving health outcomes. His innovative approaches to treating complex disorders demonstrate the importance of research and development in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…